Prevalence of and factors associated with late diagnosis of HIV in Malawi, Zambia, and Zimbabwe: Results from population-based nationally representative surveys.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 28 08 2021
accepted: 15 11 2021
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Late diagnosis of HIV (LD) increases the risk of morbidity, mortality, and HIV transmission. We used nationally representative data from population-based HIV impact assessment (PHIA) surveys in Malawi, Zambia, and Zimbabwe (2015-2016) to characterize adults at risk of LD and to examine associations between LD and presumed HIV transmission to cohabiting sexual partners. We estimated the prevalence of LD, defined as CD4 count <350 cells/μL, among adults newly diagnosed with HIV during the surveys and odds ratios for associated factors. We linked newly diagnosed adults (index cases) to their household sexual partners and calculated adjusted odds ratios for associations between LD of the index case, viral load of the index case, and duration of HIV exposure in the relationship, and the HIV status of the household sexual partner. Of 1,804 adults who were newly diagnosed with HIV in the surveys, 49% (882) were diagnosed late. LD was associated with male sex, older age, and almost five times the odds of having an HIV-positive household sexual partner (adjusted odds ratio [aOR], 4.65 [95% confidence interval: 2.56-8.45]). Longer duration of HIV exposure in a relationship and higher viral load of the index case were both independently associated with higher odds of having HIV-positive household sexual partners. Individuals with HIV exposure of more than 5 years had more than three times (aOR 3.42 [95% CI: 1.63-7.18]) higher odds of being HIV positive than those with less than 2 years HIV exposure. The odds of being HIV positive were increased in individuals who were in a relationship with an index case with a viral load of 400-3499 copies/mL (aOR 4.06 [95% CI 0.45-36.46]), 3,500-9,999 copies/mL (aOR 11.32 [95% CI: 4.08-31.39]), 10,000-49,999 copies/mL (aOR 17.07 [95% CI: 9.18-31.72]), and ≥50,000 copies/mL (aOR 28.41 [95% CI: 12.18-66.28]) compared to individuals who were in a relationship with an index case with a viral load of <400 copies/mL. LD remains a challenge in Southern Africa and is strongly associated with presumed HIV transmission to household sexual partners. Our study underscores the need for earlier HIV diagnosis, particularly among men and older adults, and the importance of index testing.

Identifiants

pubmed: 36962254
doi: 10.1371/journal.pgph.0000080
pii: PGPH-D-21-00582
pmc: PMC10021857
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000080

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S2-S5
pubmed: 34166307
J Infect Dis. 2005 May 1;191(9):1403-9
pubmed: 15809897
AIDS. 1996 Sep;10(11):1293-4
pubmed: 8883595
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
Lancet HIV. 2021 Apr;8(4):e225-e236
pubmed: 33794183
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
EClinicalMedicine. 2021 Jul 07;38:100991
pubmed: 34278282
MMWR Morb Mortal Wkly Rep. 2019 May 31;68(21):474-477
pubmed: 31145718
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):3-9
pubmed: 27509244
Clin Infect Dis. 2012 Jun;54(12):1798-805
pubmed: 22460964
J Int AIDS Soc. 2020 Jun;23 Suppl 2:e25520
pubmed: 32589360
Clin Infect Dis. 2012 Jun;54(12):1806-13
pubmed: 22460963
PLoS One. 2019 Sep 6;14(9):e0221215
pubmed: 31490938
PLoS One. 2012;7(3):e32369
pubmed: 22412867
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25321
pubmed: 31321918
AIDS. 2009 Jul 17;23(11):1397-404
pubmed: 19381076
PLoS One. 2012;7(3):e33328
pubmed: 22479384
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S73-S80
pubmed: 34166315
Curr Opin HIV AIDS. 2019 Jan;14(1):60-65
pubmed: 30394947
Clin Infect Dis. 2013 Mar;56(6):888-97
pubmed: 23223594
Clin Infect Dis. 2021 Aug 16;73(4):e1018-e1028
pubmed: 34398952
J Infect Dis. 2008 Sep 1;198(5):687-93
pubmed: 18662132
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S124-S127
pubmed: 29994834
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S6-S16
pubmed: 34166308
PLoS Med. 2013 Aug;10(8):e1001496
pubmed: 23966838
J Infect Dis. 1994 Jan;169(1):28-36
pubmed: 7903975
J Matern Fetal Neonatal Med. 2010 Oct;23(10):1091-6
pubmed: 20121393
Clin Infect Dis. 2011 Oct;53(8):817-25
pubmed: 21921225
J Int AIDS Soc. 2020 Nov;23(11):e25631
pubmed: 33225559
J Int AIDS Soc. 2017 May 15;20(1):21594
pubmed: 28530049

Auteurs

Andreas D Haas (AD)

ICAP, Columbia University, New York, New York, United States of America.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Elizabeth Radin (E)

ICAP, Columbia University, New York, New York, United States of America.

Sehin Birhanu (S)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Andrea J Low (AJ)

ICAP, Columbia University, New York, New York, United States of America.

Suzue Saito (S)

ICAP, Columbia University, New York, New York, United States of America.

Karampreet Sachathep (K)

ICAP, Columbia University, New York, New York, United States of America.

Shirish Balachandra (S)

Centers for Disease Control and Prevention, Harare, Zimbabwe.

Julius Manjengwa (J)

ICAP, Columbia University, New York, New York, United States of America.

Yen T Duong (YT)

ICAP, Columbia University, New York, New York, United States of America.

Sasi Jonnalagadda (S)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Danielle Payne (D)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

George Bello (G)

Government of Malawi, Ministry of Health, Lilongwe, Malawi.

Avi J Hakim (AJ)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Theo Smart (T)

ICAP, Columbia University, New York, New York, United States of America.

Nahima Ahmed (N)

ICAP, Columbia University, New York, New York, United States of America.

Juliana Cuervo-Rojas (J)

ICAP, Columbia University, New York, New York, United States of America.
Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.

Andrew Auld (A)

Centers for Disease Control and Prevention, Lilongwe, Malawi.

Hetal Patel (H)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Bharat Parekh (B)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Daniel B Williams (DB)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Danielle T Barradas (DT)

Centers for Disease Control and Prevention, Lusaka, Zambia.

Owen Mugurungi (O)

Government of Zimbabwe, Ministry of Health and Child Care, Harare, Zimbabwe.

Lloyd B Mulenga (LB)

Government of Zambia, Ministry of Health, Lusaka, Zambia.

Andrew C Voetsch (AC)

Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Jessica E Justman (JE)

ICAP, Columbia University, New York, New York, United States of America.

Classifications MeSH